What to know when naming medicines in Brazil

Dual scrutiny by the Brazilian Patent and Trademark Office and Health Regulatory Agency demands careful coordination to avoid rejected brands or delayed products.

Leave a Comment

Your email address will not be published. Required fields are marked *

sixteen − four =